![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Stähler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Pantuck, A. J.; Patel, A.; DeAnnuntis, L.; Bhattacharyya, H.; Ramaswamy, K.; Zanotti, G.; Lin, X.; Lechuga, M.; Serfass, L.; Paty, J. und Ravaud, A.
(2018):
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
In: Annals of Oncology, Bd. 29, Nr. 10: S. 2098-2104
Ziegelmüller, B. K.; Spek, A.; Szabados, B.; Casuscelli, J.; Clevert, D. -A. und Stähler, M.
(2018):
Epidemiologie und Diagnostik kleiner Nierentumoren.
In: Urologe, Bd. 57, Nr. 3: S. 274-279
Stähler, M.; Göbell, P. J.; Müller, L.; Overkamp, F.; Frank, M.; Kruggel, L.; Jänicke, M. und Marschner, N.
(2017):
Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma - data from the German prospective RCC-Registry.
In: Oncology Research and Treatment, Bd. 40: S. 96
Göbell, P. J.; Müller, L.; Stähler, M.; Müller, M.; Frank, M.; Kruggel, L.; Jänicke, M. und Marschner, N.
(2017):
Prognostic factors for overall survival of patients with advanced renal cell carcinoma - data from the German prospective RCC-Registry.
In: Oncology Research and Treatment, Bd. 40: S. 114
Siva, S.; Muacevic, A.; Stähler, M.; Warner, A.; Gandhidasan, S.; Ponsky, L.; Ellis, R. J.; Kaplan, I.; Mahadevan, A.; Chu, W.; Onishi, H.; Lo, S. S.; Teh, B. S.; Swaminath, A.; Correa, R. J. M. und Louie, A. V.
(2017):
Individual Patient Data Meta-analysis of SBRT Kidney: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
In: International Journal of Radiation Oncology Biology Physics, Bd. 99, Nr. 2:
S153-S154
Göbell, P. J.; Müller, L.; Stähler, M.; Müller, M.; Frank, M.; Kruggel, L.; Jänicke, M. und Marschner, N.
(2017):
Prognostic factors for overall survival of patients with advanced renal cell carcinoma - data from the German prospective RCC-Registry.
In: Annals of Oncology, Bd. 28
Powles, T.; McDermott, D. F.; Rini, B.; Motzer, R. J.; Atkins, M. B.; Fong, L.; Joseph, R. W.; Pal, S. K.; Ravaud, A.; Bracarda, S.; Suarez Rodriguez, C.; Maio, M.; Gore, M.; Grünwald, V.; Stähler, M.; Qiu, J.; Thobhani, A.; Huseni, M.; Schiff, C. und Escudier, B.
(2017):
IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC).
In: Annals of Oncology, Bd. 28
Stähler, M.; Müller, L.; Göbell, P. J.; Overkamp, F.; Frank, M.; Kruggel, L.; Jänicke, M. und Marschner, N.
(2017):
Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma: Data from the German prospective RCC-Registry.
In: Annals of Oncology, Bd. 28
Stähler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Kliment, J.; Pantuck, A. J.; Patel, A.; Deannuntis, L.; Bhattacharyya, H.; Lin, X.; Lechuga, M.; Serfass, L.; Patard, J.-J. und Ravaud, A.
(2017):
Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial.
In: Annals of Oncology, Bd. 28